Trial reporting in ClinicalTrials.gov - The final rule

New England Journal of Medicine

Volumn 375, Issue 20, 2016, Pages 1998-2004

  Zarin, Deborah A ^a   Tse, Tony ^a   Williams, Rebecca J ^a   Carr, Sarah ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); DATA ANALYSIS; DEVICE APPROVAL; DOCUMENTATION; HEALTH CARE POLICY; INFORMATION DISSEMINATION; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; REGISTRATION; STUDY DESIGN; FACTUAL DATABASE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; GOVERNMENT REGULATION; LEGISLATION AND JURISPRUDENCE; MANDATORY PROGRAM; REGISTER; STANDARDS; UNITED STATES;

CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; GOVERNMENT REGULATION; MANDATORY PROGRAMS; REGISTRIES; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84995543060     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsr1611785     Document Type: Article

References (17)

1. Food and Drug Administration Amendments Act of 2007, Public Law 110-85. September 27, 2007. (http://www.gpo.gov/ fdsys/ pkg/ PLAW-110publ85/ pdf/ PLAW-110publ85.pdf).
2. Anderson ML, Chiswell K, Peterson ED, Tasneem A, Topping J, Califf RM. Compliance with results reporting at ClinicalTrials.gov. N Engl J Med 2015; 372: 1031-9.
3. Notice of proposed rulemaking: clinical trials registration and results submission. Fed Regist 2014; 79: 69566-680 (http:// federalregister.gov/ a/ 2014-26197).
4. Zarin DA, Tse T, Sheehan J. The proposed rule for U.S. clinical trial registration and results submission. N Engl J Med 2015; 372: 174-80.
5. Clinical trials registration and results submission docket folder (NIH-2011-0003). March 21, 2014 (https:/ / www.regulations.gov/ docket?D=NIH-2011-0003).
6. Department of Health and Human Services. Final rule - clinical trials registration and results information submission. Fed Regist 2016; 81:64981-5157.
7. Food and Drug Administration Modernization Act of 1997. Public Law 105-11. November 21, 1997 (http://www.fda.gov/ downloads/ RegulatoryInformation/ Legislation/ Significant AmendmentstotheFDCAct/ FDAMA/ FullTextofFDAMAlaw/ UCM089145.pdf).
8. De Angelis C, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 2004; 351: 1250-1.
9. Zarin DA, Ide NC, Tse T, Harlan WR, West JC, Lindberg DA. Issues in the registration of clinical trials. JAMA 2007; 297: 2112-20.
10. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The Clinical-Trials.gov results database - update and key issues. N Engl J Med 2011; 364: 852-60.
11. National Institutes of Health. NIH policy on dissemination of NIH-funded clinical trial information. Fed Regist 2016; 81: 64922-8.
12. ClinicalTrials.gov. Review criteria and other support materials (https:/ / clinicaltrials.gov/ ct2/ manage-recs/ resources# ReviewCriteria).
13. Dickersin K, Rennie D. The evolution of trial registries and their use to assess the clinical trial enterprise. JAMA 2012; 307: 1861-4.
14. Riveros C, Dechartres A, Perrodeau E, Haneef R, Boutron I, Ravaud P. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLoS Med 2013; 10(12): e1001566.
15. Chan AW, Song F, Vickers A, et al. Increasing value and reducing waste: addressing inaccessible research. Lancet 2014; 383: 257-66.
16. Zarin DA, Tse T, Ross JS. Trial-results reporting and academic medical centers. N Engl J Med 2015; 372: 2371-2.
17. Hudson KL, Lauer MS, Collins FS. Toward a new era of trust and transparency in clinical trials. JAMA (in press).